TNF-α blockade mitigates immune checkpoint–related nephritis in a humanized mouse model
JCI Insight · 2026
DOI: 10.1172/jci.insight.199694 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2026. Verfasst von Victor D Cuenca Narvaez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Nephrology and Hypertension. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Tumor Necrosis Factor-alpha, Nephritis, Interstitial, Tumor Necrosis Factor Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NA, Mayo CCaTS grant.
Abstract (Originalsprache)
Immune checkpoint inhibitors (ICIs) can cause immune-related adverse events (irAEs), with acute interstitial nephritis (ICI-AIN) being the most common irAE. While the exact mechanism remains unclear, upregulation of IFN-γ and TNF-α pathways has been implicated. This study used a humanized chimeric PD-1/PD-L1 mouse model to assess renal effects of ICIs, alone or combined with proinflammatory cytokines, and to test if selective TNF-α blockade could prevent ICI-AIN. Mice were randomly divided into 4 experimental groups: Control, ICI-Only, ICI-Cytokines (ICI-Cyt), and ICI-Block (ICI-TNF-α blockade). Renal function and cytokine profiles were assessed, while kidney tissue was analyzed using microscopy and single-cell RNA-seq. Histology revealed increased renal infiltration of CD4 + /CD8 + T cells in ICI-treated groups and decreased TNF-α expression following TNF-α blockade. Additionally, kidney tissue ELISA demonstrated reduced IFN-γ levels following TNF-α blockade. Plasma IL-6, MCP-1, and TNF-α were lower in ICI-Block mice. Single-cell RNA-seq revealed shifts in immune cell populations and genes of interest including Bcl2a1 , Icos , Il18r1 , Ccr2 , and Jaml . This humanized model replicates ICI-AIN key features, revealing a synergistic role of ICIs and proinflammatory cytokines. TNF-α blockade demonstrated protective effects, supporting its potential role in mitigating the risk of ICI-AIN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Nephrology and Hypertension.
- Department of Cardiovascular Medicine.
- Department of Biochemistry and Molecular Biology.
- Department of Immunology.
- Department of Physiology and Biomedical Engineering, and.
- Department of Urology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Förderung
- NA
- Mayo CCaTS grant
Zitieren
APA
Cuenca Narvaez, V. D., Nava Chavez, C., Al Refai, O., Jacobs, J. E., Gutierrez, L. E., Zhang, S., Li, X., Hirdler, J. B., Romero, M. F., Herrmann, J., Li, X., Dong, H., Eirin, A., & Herrmann, S. M. (2026). TNF-α blockade mitigates immune checkpoint–related nephritis in a humanized mouse model. JCI Insight. https://doi.org/10.1172/jci.insight.199694
Vancouver
Cuenca Narvaez VD, Nava Chavez C, Al Refai O, Jacobs JE, Gutierrez LE, Zhang S, et al. TNF-α blockade mitigates immune checkpoint–related nephritis in a humanized mouse model. JCI Insight. 2026. doi:10.1172/jci.insight.199694
BibTeX
@article{CuencaNarvaez2026,
author = {Cuenca Narvaez, Victor D and Nava Chavez, Coraima and Al Refai, Omar and Jacobs, Johanna Ej and Gutierrez, Luis E and Zhang, Song and Li, Xiaoyan and Hirdler, Jacob B and Romero, Michael F and Herrmann, Joerg and Li, Xiaogang and Dong, Haidong and Eirin, Alfonso and Herrmann, Sandra M},
title = {TNF-α blockade mitigates immune checkpoint–related nephritis in a humanized mouse model},
journal = {JCI Insight},
year = {2026},
doi = {10.1172/jci.insight.199694}
}
EUVIMED